Fat Bastard supports cancer

September 15, 2007 on 1:34 am | In Uncategorized | Comments Off
I'm a big fan of Fat Bastard wine, which I picked up a bottle of a few years back simply because of the odd name. If you enjoy their wine too be sure to pick some up during the months of September and October because the makers will be donating $0.25 from every bottle sold to breast cancer charities.

It might seem to be a bit of a contradiction to sell alcohol in support of cancer, but actually wine (in moderation) can help reduce to your risk of several types of cancer, not to mention heart disease. Just make sure you stick to one glass a night and enjoy the benefits of a good vintage.

I'm curious to know that you think though. Is it wrong to sell wine to raise money for breast cancer?

Tags:breast cancer, BreastCancer, charity, fat bastard, FatBastard, research, wine

Fentora cancer-related drug deaths confirmed by Cephalon

September 15, 2007 on 1:34 am | In Uncategorized | Comments Off
It's never a good thing when a drugmaker sends letters to doctors saying that a drug they are prescribing has resulted in confirmed deaths.

But that is what Cephalon did this week, as it admitted its cancer drug -- Fentora - has been linked to some patient deaths. Fentora, used to treat acute cancer pain, are sometimes prescribed for other pain-related ailments.

Cephalon took issue with the apparent claim that it markets Fentora for uses other than cancer pain, even though some doctors use it "off label" in normal practice.

Tags:cancer, cephalon, fentora

Testicular cancer linked to birth weight

September 15, 2007 on 1:34 am | In Uncategorized | Comments Off
There might be some bad news out there for men with above or below normal birth weights -- new studies are showing that they might be at a high risk for testicular cancer than those who were born a more normal size. To be more precise, men with low birth weights were 18% more likely to develop testicular cancer than their normal-sized counterparts, and high birth weight men were 12% more likely to be diagnosed with the disease. It should be noted, however, that the findings are only try to seminoma testicular cancer, which is the most prevalent type.

Researchers are not indicating whether they believe there might be a reason to these findings. I wonder if some unhealthy habits of mothers that may have lead to low or high birth weights could be playing a role in the health of their sons later in life? What do you think?

Tags:birth weight, BirthWeight, high, low, normal, seminoma, testicular cancer, TesticularCancer

More men need prostate cancer testing

September 15, 2007 on 1:34 am | In Uncategorized | Comments Off In Canada, health officials are wanting more men in the high-risk group (most likely, middle aged) to get screened for prostate cancer. Why? Well, only two in every five men in that country from within that group apparently have tested for prostate cancer in the past year. That's just too low.

An astounding 39 percent (only) of men over the age of 45 have taken blood tests to measure the prostate specific antigen levels, with only 33 percent having undergone a digital rectal exam.

In other words, there could be a lot more undiagnosed prostate problems under development with such a low amount of high-risk men being tested.

Tags:cencer, prostarte, screening

Routine lung cancer screening gets thumbs down

September 15, 2007 on 1:34 am | In Uncategorized | Comments Off Lung cancer screening by using CT scans may not be the best thing to do, according to a recent report by the American College of Chest Physicians (ACCP).

That group stated that, outside of research studies, studying lung cancer using CT technology is not worth the risk since it rarely (if at all) leads to reduced lung cancer deaths.

The reason? Sounds to easy, but with CT tests only looking at lung cancer detection, actual survival rates were not looked at in many cases (and weren't affected anyway).

Tags:cancer, lung, screening

« Previous Page

Powered by WordPress with Pool theme design by Borja Fernandez.